Table 2 One-year and five-year relative survival 1 by Indigenous status and cancer site/type, Australia, 2001-2005
| Â | Indigenous | Non-indigenous2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Cases | One-year | Five-year | Cases | One-year | Five-year | ||||
Cancer site/type | n | % | (95% CI) | % | (95% CI) | n | % | (95% CI) | % | (95% CI) |
Head and neck (C1-14, C30-32) | 236 | 60.3 | (53.6-66.4) | 32.4 | (25.6-39.5) | 11 893 | 86.1 | (85.5-86.8) | 65.9 | (64.9-66.9) |
Stomach (C16) | 73 | 39.8 | (28.3-51.1) | 16.9 | (8.0-29.0) | 9 349 | 56.1 | (55.1-57.1) | 30.7 | (29.6-31.7) |
Colorectal (C18-20) | 306 | 80.1 | (74.8-84.6) | 58.5 | (50.9-65.7) | 62 021 | 85.6 | (85.3-85.9) | 66.3 | (65.9-66.8) |
Anus (C21) | 22 | 73.8 | (49.9-88.0) | 49.1 | (20.9-73.8) | 1 304 | 91.7 | (89.9-93.1) | 70.4 | (67.3-73.4) |
Liver (C22) | 83 | 24.8 | (16.0-34.6) | 11.2 | (5.1-20.0) | 4 500 | 43.4 | (41.9-44.9) | 19.9 | (18.5-21.2) |
Pancreas (C25) | 91 | 26.3 | (17.6-35.9) | 11.2 | (5.4-19.5) | 9 667 | 27.6 | (26.7-28.5) | 7.6 | (7.0-8.3) |
Lung (C33-34) | 500 | 29.4 | (25.4-33.5) | 9.1 | (6.3-12.5) | 42 139 | 43.4 | (42.9-43.9) | 16.7 | (16.3-17.2) |
Melanoma (C43) | 59 | 95.6 | (84.4-100.7) | 73.8 | (55.5-88.5) | 48 592 | 97.9 | (97.7-98.1) | 92.4 | (91.9-92.8) |
Breast (C50) | 420 | 94.1 | (91.0-96.4) | 80.1 | (74.3-85.2) | 59 640 | 97.9 | (97.7-98.0) | 89.5 | (89.1-89.8) |
Cervix (C53) | 109 | 79.8 | (70.8-86.5) | 57.6 | (46.6-67.4) | 3 475 | 90.8 | (89.7-91.7) | 78.3 | (76.7-79.8) |
Uterus (C54) | 96 | 85.2 | (75.9-91.4) | 78.7 | (66.7-88.2) | 7 969 | 94.0 | (93.5-94.6) | 84.6 | (83.6-85.7) |
Ovary (C56) | 53 | 77.1 | (62.9-86.8) | 50.1 | (33.6-65.1) | 5 777 | 83.5 | (82.5-84.5) | 53.1 | (51.6-54.6) |
Prostate (C61) | 181 | 90.4 | (84.0-94.9) | 83.6 | (72.5-93.2) | 68 475 | 97.3 | (97.1-97.4) | 91.0 | (90.6-91.4) |
Testis (C62) | 25 | 100.5 | (100.5-100.5) | 94.5 | (73.6-100.5) | 3 209 | 98.8 | (98.3-99.2) | 96.9 | (96.0-97.6) |
Kidney (C64) | 69 | 77.5 | (65.2-86.3) | 68.1 | (53.0-80.7) | 10 522 | 84.9 | (84.2-85.6) | 73.2 | (72.1-74.2) |
Bladder (C67) | 53 | 61.5 | (46.4-74.0) | 54.7 | (36.1-72.6) | 11 270 | 85.2 | (84.5-85.9) | 68.1 | (66.9-69.2) |
Brain (C71) | 48 | 58.9 | (43.6-71.4) | 42.2 | (26.9-56.9) | 6 800 | 64.3 | (63.2-65.5) | 40.4 | (39.2-41.7) |
Thyroid (C73) | 74 | 93.0 | (83.9-97.5) | 85.0 | (69.3-94.5) | 6 809 | 97.0 | (96.5-97.4) | 96.0 | (95.3-96.6) |
Hodgkin lymphoma (C81) | 26 | 96.8 | (76.2-100.1) | 100.6 | (79.2-104.0) | 2 290 | 96.0 | (95.1-96.8) | 90.3 | (88.8-91.7) |
NHL (C82-85, C96) | 101 | 67.4 | (56.9-76.1) | 52.0 | (37.3-65.8) | 18 392 | 85.5 | (85.0-86.0) | 73.7 | (72.9-74.5) |
Leukemia (C91-95) | 108 | 64.6 | (54.5-73.1) | 53.7 | (42.7-63.9) | 12 864 | 80.3 | (79.5-81.0) | 63.9 | (62.9-64.9) |
Unknown primary (C76-80) | 196 | 29.2 | (22.8-35.8) | 14.9 | (9.9-21.1) | 14 997 | 35.6 | (34.9-36.4) | 21.3 | (20.6-22.1) |
Other | 363 | 61.1 | (55.7-66.1) | 40.3 | (34.4-46.2) | 42 463 | 78.5 | (78.1-78.9) | 57.2 | (56.7-57.8) |
All cancers (C00-96, D45-47) | 3 292 | 63.8 | (62.1-65.5) | 46.7 | (44.6-48.7) | 464 417 | 83.4 | (83.3-83.5) | 70.0 | (69.8-70.2) |